VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $592,526,000 | -55.5% | 5,829,079 | -21.9% | 2.53% | -53.3% |
Q3 2015 | $1,331,032,000 | +12.8% | 7,461,780 | +40.5% | 5.42% | +22.8% |
Q2 2015 | $1,179,648,000 | +6.6% | 5,310,143 | -4.7% | 4.41% | +5.4% |
Q1 2015 | $1,106,206,000 | -99.9% | 5,569,460 | -32.5% | 4.19% | -15.4% |
Q4 2014 | $1,180,784,295,000 | +81821.8% | 8,250,886 | -24.9% | 4.95% | -12.1% |
Q3 2014 | $1,441,355,000 | +13.3% | 10,985,940 | +8.9% | 5.63% | +9.5% |
Q2 2014 | $1,272,481,000 | +9.5% | 10,089,450 | +14.4% | 5.14% | +1.8% |
Q1 2014 | $1,162,306,000 | +27.6% | 8,816,702 | +13.7% | 5.05% | +29.0% |
Q4 2013 | $910,611,000 | +12.2% | 7,756,485 | -0.3% | 3.92% | +8.1% |
Q3 2013 | $811,865,000 | +17.7% | 7,781,707 | -2.9% | 3.62% | +7.9% |
Q2 2013 | $689,717,000 | – | 8,012,507 | – | 3.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |